FACTORY-DIRECT RESEARCH MATERIALS
ManufacturingResourcesProject enquiries
Pepverlabs Request a quoteGet a quote

GLOW70 |(BPC157 10mg+GHK-CU50mg+TB500 10mg) | 70mg/vial,10vial/kit| >99% Purity

(30 customer reviews)

GLOW70 combines BPC-157, GHK-Cu and TB-500 in one research formulation. The listed composition is 10 mg BPC-157, 50 mg GHK-Cu and 10 mg TB-500, totaling 70 mg per vial.

Product Name
GLOW70 (BPC157 10 mg +GHK-CU50 mg +TB500 10 mg )
CAS Number
GHK-Cu:89030-95-5 BPC-157:137525-51-0 TB500:885340-08-9
Purity (HPLC)
≥ 99.0%
pH Level
Approx.4.0–6.0
Appearance
White Lyophilized/Crystalline Powder
Storage
Store at -20°C (Protect strictly from light and moisture)

Available specifications

70 mg × 10 vials

Request a quotation for your preferred specification and quantity.

Add to your enquiry

Description

Basic introduction

GLOW70 is a multi-component catalog formulation containing BPC-157, GHK-Cu and a TB-500-labeled material. The listing describes a 70 mg total blend; the individual component amounts should be confirmed with the selected specification and batch report.

Each constituent has a different research background. The combined product should therefore be evaluated as its own preparation, with separate attention to composition, compatibility and the identity of the thymosin-related component.

Mechanism of action · Research context

BPC-157 component

BPC-157 research includes tendon-cell models. Published work on growth-factor responsiveness provides a component-level topic, rather than proof of a response from the complete GLOW70 mixture.

Copper-peptide component

GHK-Cu adds copper-complex chemistry to the formulation. Its presence makes metal composition and compatibility relevant analytical questions alongside peptide identity.

Thymosin-related component

The TB-500 designation requires sequence confirmation. Full-length thymosin beta-4 literature cannot establish the identity or activity of an unspecified fragment within a mixture.

Extended research considerations

Component-resolved analysis

A blend needs more than a total purity number. Where appropriate, verify each component with a method capable of distinguishing it from the other constituents.

Testing combination effects

A synergy claim requires comparative evidence. Include individual-component and matched-mixture conditions rather than inferring combined activity from three separate bodies of literature.

Formulation stability

Compatibility belongs to the complete preparation. Changes in recovery, appearance or analytical profile should be investigated without assuming that each component behaves as it would in isolation.

Material and packaging

Listed appearance: White Lyophilized/Crystalline Powder.

Available kit specifications: 70 mg × 10 vials. Select an option above to view its current price and availability.

Storage and handling

Source-listed storage condition: Store at -20°C (Protect strictly from light and moisture). Follow the handling instructions supplied with the actual batch and your laboratory's procedures.

Analytical documentation

Contact us to request analytical documentation for the required material and batch. Confirm the material identity, batch number and test date when reviewing a report.

Scientific references

These publications describe the studied molecules and experimental models. They do not certify the identity, quality or effects of a particular supplied batch.

  • BPC-157 component research
  • GHK-Cu component research
  • Full-length thymosin beta-4 research

Additional information

Specification

70 mg × 10 vials

30 reviews for GLOW70 |(BPC157 10mg+GHK-CU50mg+TB500 10mg) | 70mg/vial,10vial/kit| >99% Purity

  1. Neva W. –

    This listing only supplies standardized 70mg composite vials with fixed 10/50/10mg ratios of the three peptides, perfectly matched for medium-scale in-vivo wound healing and dermal anti-aging trials. I only reconstitute a single vial per testing session to avoid wasting diluted blend, which rapidly loses combined biological activity once exposed to room light and ambient temperature.

  2. Rhea D. –

    A new lab assistant accidentally left an unopened GLOW70 vial out at room temperature for three full days. Post-assessment testing revealed severe powder clumping and uneven loss of biological activity across BPC157, GHK-Cu and TB500, reinforcing that strict -20°C dark dry storage is non-negotiable to preserve the balanced blend’s performance.

  3. Vada F. –

    Advanced industrial co-lyophilization manufacturing yields ultra-fine free-flowing crystalline powder without hard compacted sediment chunks settled at vial bottoms. When I only require tiny microgram-level samples for early-stage preliminary screening assays, I can extract partial dry powder without fully dissolving the entire vial to conserve expensive composite peptide lab stock.

  4. Wyn R. –

    International bulk shipping packaging uses individual shockproof foam slots for each glass vial to prevent collision and breakage during overseas transit. I’ve placed four separate cross-border bulk orders so far, and zero vials arrived cracked, leaking or contaminated upon lab delivery.

  5. Quinten F. –

    The specialized co-lyophilized buffer blend drastically cuts composite peptide adhesion to inner glass vial walls post-dissolution. I recover nearly the complete labeled 70mg total powder mass from each vial, eliminating major dosing inaccuracies for quantitative collagen synthesis and inflammatory tissue signaling research.

Add a review

Your email address will not be published. Required fields are marked *

PEPVERLABS / RESEARCH CATALOG

Find your research material.

30 research materialsPRODUCT NAME / CODE